Tata India Pharma & Healthcare Fund - Direct (G) logo

Tata India Pharma & Healthcare Fund Direct Growth

NAV ₹36.15 as on 17 Nov 2025

RiskVery High

Fund Size₹1,324.90Cr

NAV₹36.15 as on 17 Nov 2025
RiskVery High
Fund Size₹1,324.90Cr

Download 3-in-1 Torus App
Trade at flat ₹11/order & Zero AMC
demat with one powerful SuperApp.

Investment Details
Top Rated Funds

Lock-in

No Lock-in

Min One Time Amount

₹5,000

Min Withdrawal Amount

₹-

Min SIP Amount

₹100

Min Additional Amount

₹1,000

Exit Load

0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.

Basic Details

Age

9 years 11 months (Since Dec 28, 2015)

Return since Launch

13.87%

Expense ratio

0.62%

Type

OPEN

AUM (Fund Size)

₹1,324.90

Risk Grade

Very High

Benchmark

BSE Healthcare TRI

Calculate Your Returns
Select Duration
Choose Amount
Returns
Total investment of ₹2,40,000
Would have become ₹61,949 (+209.74%)
Fund Manager

Name:

Rajat Srivastava

Experience:

From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o

Asset Allocation
RiskometerLevel of risk in the scheme
Moderate
High
Low
Very
High

Your investment will be at Very High Risk

Fund house & investment objective
Rank (total assets)#9 in India
Total AUM₹2,17,939.09Cr
Date of Incorporation15 Mar 1994
Tata India Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 28 Dec 2015. The fund currently has an Asset Under Management(AUM) of ₹2,17,939.09 Cr and the Latest NAV as of 17 Nov 2025 is ₹36.15.
The Tata India Pharma & Healthcare Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹100 . Minimum Lumpsum Investment is ₹5,000. Exit load of 0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment. .
...Read more
Returns and Rankings

Category: Equity Sectoral / Thematic

1Y3Y5YAll
Fund returns6.67%7.48%3.63%1.45%
Category average8.02%6.14%3.98%-
Rank within category1202858-

FAQ’s

What kind of returns does Tata India Pharma & Healthcare Fund Direct Growth provide?

Tata India Pharma & Healthcare Fund Direct Growth has given a return of 24.15% in the past 3 years.

What is the expense ratio charged by Tata India Pharma & Healthcare Fund Direct Growth?

The Expense Ratio charged by Tata India Pharma & Healthcare Fund Direct Growth is 0.62%.

What is the AUM size of Tata India Pharma & Healthcare Fund Direct Growth?

The AUM size of Tata India Pharma & Healthcare Fund Direct Growth is ₹1,324.90Cr.

What is the minimum SIP amount that you can invest in Tata India Pharma & Healthcare Fund Direct Growth?

₹100 is the minimum SIP amount that you can invest in Tata India Pharma & Healthcare Fund Direct Growth .

What are the top stock holdings of Tata India Pharma & Healthcare Fund Direct Growth?

The top stock holdings of Tata India Pharma & Healthcare Fund Direct Growth include , Sun Pharmaceutical Industries Ltd , Lupin Ltd , Torrent Pharmaceuticals Ltd and Alkem Laboratories Ltd.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.